Philip D. Gregory

Philip D. Gregory (senior executive) discloses dealings in 2 companies, chiefly 2seventy bio, Inc. and bluebird bio, Inc. Over a trading history stretching from 3 May 2021 to 8 January 2024, the count stands at 16 filings.

Sales make up the whole of the open-market record (10 sales, €296k). Besides market trades, the filings include 5 share grants. So far in 2024, the count stands at no purchases and 2 sales.

The latest filing, published on 9 January 2024, reports an open-market sale of €2,726 in 2seventy bio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.